Quest Diagnostics is to introduce the new Simplexa Flu A/B & RSV Direct test in Europe.

The CE marked Simplexa Direct test will run on the 3M Integrated Cycler to detect influenza A and B and respiratory syncytial virus.

Developed by the Quest’s Focus Diagnostics business, it uses a proprietary technique to eliminate the nucleic acid sample-extraction process, allowing it to deliver results faster.